A special master overseeing opioid litigation is resisting a request to step down after he mistakenly sent lawyers a “reply all” email with private notes to himself.
The special master overseeing the massive opioid multidistrict litigation against pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. is fighting a disqualification bid filed following his reply-all flub, telling an Ohio federal judge on Thursday that it is "hokey" but true that every day he reminds himself of the role's "honor and privilege."
Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and